رفتن به محتوای اصلی

Is routine veno-venous bypass necessary in liver transplantation?

در دسترس به زیان‌های

During liver transplantation major veins are clamped (blocked using clamps) by the surgeon in order to complete the operation. This can decrease the blood returning to the heart which has the potential to decrease the blood pressure and the blood flow to the vital organs. To avoid this, diverting the blood flow through an external circuit bypassing the clamps and returning this blood to the heart (veno-venous bypass) has been advocated by some. However, the use of veno-venous bypass is associated with a risk of major life threatening complications and also minor complications. Thus, the use of veno-venous bypass is controversial.

We systematically searched various medical databases to determine whether veno-venous bypass is required routinely during liver transplantation. We identified a total of three randomised clinical trials with high risk of systematic error and high risk of random errors which compared veno-venous bypass (n = 65) with no veno-venous bypass (n = 66). None of the trials reported patient or graft survival. There were no differences regarding kidney failure or blood transfusion requirements between the two groups. None of the trials reported on the complications related to veno-venous bypass or the requirement of veno-venous bypass in the control group. We also identified one trial with high risk of systematic error and high risk of random errors which compared needle technique (percutaneous approach) (n = 20) with open technique (n =19) of veno-venous bypass. The patient or graft survival was not reported in this trial. There was no difference in veno-venous bypass related complications between the two groups. The operating time was shorter in the percutaneous technique group. There is currently no evidence to support the routine use of veno-venous bypass in liver transplantation.

پیشینه

Veno-venous bypass is used to overcome the effects of clamping of the inferior vena cava and portal vein during liver transplanation. The routine use of veno-venous bypass is, however, controversial.

اهداف

To compare the benefits and harms of veno-venous bypass (irrespective of open or percutaneous technique; heparin-coated or no heparin-coating) versus no veno-venous bypass during liver transplantation. To compare the benefits and harms of the different techniques of veno-venous bypass during liver transplantation.

روش‌های جست‌وجو

We searched The Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE, EMBASE, and Science Citation Index Expanded until December 2010.

معیارهای انتخاب

We included randomised clinical trials comparing veno-venous bypass during liver transplantation (irrespective of language or publication status).

گردآوری و تجزیه‌وتحلیل داده‌ها

Two authors independently assessed trials for inclusion and independently extracted data. We analysed the data with both the fixed-effect and the random-effects models using RevMan Analysis. For continuous outcomes, we calculated the mean difference (MD) with 95% confidence intervals (CI) based on intention-to-treat or available case analysis. For binary outcomes, we used the Fisher's exact test since none of the comparisons of binary outcomes included more than one trial.

نتایج اصلی

We identified three trials with high risk of bias which compared veno-venous bypass (n = 65) versus no veno-venous bypass (n = 66). None of the trials reported patient or graft survival. There were no significant differences regarding renal failure or blood transfusion requirements between the two groups. None of the trials reported on the morbidity related to veno-venous bypass or the requirement of veno-venous bypass in the control group.

We identified one trial with high risk of bias which compared percutaneous (n = 20) versus open technique (n =19) of veno-venous bypass. The patient or graft survival was not reported. There was no difference in veno-venous bypass related morbidity between the two groups. The operating time was significantly shorter in the percutaneous technique group (MD -59 minutes; 95% CI -102 to -16).

نتیجه‌گیری‌های نویسندگان

There is no evidence to support or refute the use of veno-venous bypass in liver transplantation. There is no evidence to prefer any particular technique of veno-venous bypass in liver transplantation.

استناد
Gurusamy KS, Koti R, Pamecha V, Davidson BR. Veno-venous bypass versus none for liver transplantation. Cochrane Database of Systematic Reviews 2022, Issue 4. Art. No.: CD007712. DOI: 10.1002/14651858.CD007712.pub2.

استفاده ما از cookie‌ها

ما برای کارکردن وب‌گاه از cookie‌های لازم استفاده می‌کنیم. ما همچنین می‌خواهیم cookie‌های تجزیه و تحلیل اختیاری تنظیم کنیم تا به ما در بهبود آن کمک کند. ما cookie‌های اختیاری را تنظیم نمی کنیم، مگر این‌که آنها را فعال کنید. با استفاده از این ابزار یک cookie‌ روی دستگاه شما تنظیم می‌شود تا تنظیمات منتخب شما را به خاطر بسپارد. همیشه می‌توانید با کلیک بر روی پیوند «تنظیمات Cookies» در پایین هر صفحه، تنظیمات cookie‌ خود را تغییر دهید.
برای اطلاعات بیشتر در مورد cookie‌هایی که استفاده می‌کنیم، صفحه cookie‌های ما را ملاحظه کنید.

پذیرش تمامی موارد
پیکربندی کنید